Advertisement
Home »

piRNA-1742 promotes renal cell carcinoma malignancy by regulating USP8 stability through binding to hnRNPU and thereby inhibiting MUC12 ubiquitination.

Jun 19, 2023

ABOUT THE CONTRIBUTORS

  • Wentao Zhang

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China.

    Zongtai Zheng

    Department of Urology, Guangdong Second Provincial General Hospital, Guangzhou, P. R. China.

    Keyi Wang

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China.

    Weipu Mao

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China.

    Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, P. R. China.

    Xue Li

    Department of Pathology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, P. R. China.

    Guangchun Wang

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China.

    Yuanyuan Zhang

    Institute for Regenerative Medicine, Wake Forest University, Winston-Salem, NC, USA.

    Jianhua Huang

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China.

    Ning Zhang

    Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

    Pengfei Wu

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China.

    Ji Liu

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China.

    Haimin Zhang

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China.

    Jianping Che

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China.

    Bo Peng

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China. pengbo6908@163.com.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China. pengbo6908@163.com.

    Junhua Zheng

    State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University, Shanghai, P. R. China. zhengjh0471@sina.com.

    Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P. R. China. zhengjh0471@sina.com.

    Wei Li

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China. weili06@tongji.edu.cn.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China. weili06@tongji.edu.cn.

    Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. weili06@tongji.edu.cn.

    Xudong Yao

    Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, P. R. China. yaoxudong1967@163.com.

    Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, P. R. China. yaoxudong1967@163.com.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement